Journal:

Article Title: Preclinical and Clinical Performance of the Efoora Test, a Rapid Test for Detection of Human Immunodeficiency Virus-Specific Antibodies

doi: 10.1128/JCM.43.5.2399-2406.2005

Figure Lengend Snippet: Efoora HIV rapid test preclinical testing locations and information

Article Snippet: Specimens tested at sites 2 and 4 were predominantly, if not exclusively, from patients whose infection originated in the United States and thus were probably subtype B. table ft1 table-wrap mode="anchored" t5 TABLE 2. caption a7 Site Date No. of specimens tested Reference test(s) a Specimen type(s) U.S. East Coast March 1999 1,931 Genetic Systems HIV-1/2, Bio-Rad WB Serum February 2000 291 Genetic Systems HIV-1/2, Genetic Systems rLAV EIA, Bio-Rad WB Fresh whole blood February 2001 528 Genetic Systems HIV-1/2, Bio-Rad WB Serum, plasma, whole blood U.S. Midwest June 1999 1,076 Genetic Systems HIV-1/2, Abbott HIV-1/2, Bio-Rad WB Serum, plasma Ivory Coast, West Africa June 1999 962 Enzygnost Plus, immunocapture HIV Serum, plasma South Africa March 2000 150 Genetic Systems HIV-1/2 Serum, plasma, whole blood Open in a separate window a rLAV, recombinant lymphadenopathy-associated virus (HIV-1).

Techniques: